Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction

LV volume and function after AMI in all patients. A, LVEDVI, LVESVI, and LVEF at admission (acute phase) in losartan (open bar) and enalapril groups (closed bar). B, LVEDVI, LVESVI, and LVEF at 6 months after the onset of AMI in losartan (open bar) and enalapril groups (closed bar). C, Changes in LVEDVI, LVESVI, and LVEF from acute phase to 6 months after the onset of AMI in losartan (open bar) and enalapril groups (closed bar). *P < .05 versus losartan group.

LV volume and function after AMI in the patients with anterior myocardial infarction and culprit lesion in LAD. A, LVEDVI, LVESVI, and LVEF at admission in losartan (open bar) and enalapril groups (closed bar). B, LVEDVI, LVESVI, and LVEF at 6 months after the onset of AMI in losartan (open bar) and enalapril groups (closed bar). C, Changes in LVEDVI, LVESVI, and LVEF from acute phase to 6 months after the onset of AMI in losartan (open bar) and enalapril groups (closed bar). *P < .05 versus losartan group.

Plasma level of BNP at 6 months after the onset of AMI in losartan (open bar) and enalapril groups (closed bar) in all patients (A) and patients with anterior myocardial infarction (MI) and culprit lesion in LAD (B). *P < .05 versus control group.